+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Isoamyl 4-Methoxycinnamate Market - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 185 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6145540
UP TO OFF until Dec 31st 2026
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Isoamyl 4-methoxycinnamate occupies a critical position as an organic UV filter utilized extensively in sun care and cosmetic formulations to provide broad-spectrum ultraviolet protection. Its molecular configuration ensures high photostability and strong absorption in the UVB region, which has made it a preferred ingredient for sunscreens and skin care products aiming to deliver efficacy without compromising sensory experience. Furthermore, the compound’s compatibility with a diverse range of emollients and emulsifiers has established it as a cornerstone of advanced formulation research, where attributes like safety, stability, and aesthetic finish are paramount.

Simultaneously, the global personal care and pharmaceutical sectors have intensified their focus on multifunctional ingredients that transcend single-use applications. End users now expect UV filters to contribute antioxidant properties, controlled-release capabilities, or enhanced skin health benefits while still delivering reliable protection from harmful rays. This convergence of performance demands has positioned isoamyl 4-methoxycinnamate at the heart of industry R&D efforts, driving innovation in product differentiation and formulation optimization.

In light of these developments, a foundational comprehension of isoamyl 4-methoxycinnamate’s intrinsic qualities and its role within evolving application domains is essential. An integrated analysis that considers molecular advantages, formulation synergies, and market drivers provides the necessary context for stakeholders seeking to chart a course through this competitive landscape. This executive summary thus sets the stage for an in-depth examination of key trends, regulatory influences, segmentation insights, and strategic imperatives shaping the future of this indispensable UV filter

Identifying Transformative Shifts Reshaping the Isoamyl 4-Methoxycinnamate Landscape Driven by Innovation, Regulation, and Consumer Demand Trends

The isoamyl 4-methoxycinnamate landscape is undergoing transformative shifts driven by regulatory reforms, technological breakthroughs, and evolving consumer preferences. In Europe, the recent updates to chemical registration protocols under REACH have intensified requirements for safety data and sustainability credentials, compelling ingredient suppliers to invest in greener synthesis routes. Concurrently, the U.S. Food and Drug Administration has proposed tighter labeling guidelines for sunscreen products, prompting manufacturers to reassess their portfolios and optimize formulation transparency.

Technological innovation is further reshaping market dynamics as researchers refine encapsulation techniques and delivery systems to enhance UV filter performance. Nanoemulsion platforms and microencapsulation methodologies have been leveraged to improve photostability and accelerate skin absorption. At the same time, interest in bio-based feedstocks and enzymatic synthesis is gaining momentum, reflecting a broader industry pivot toward sustainable chemistry initiatives that reduce environmental impact without compromising functional efficacy.

Moreover, shifting consumer behaviors are redefining product development priorities. Modern consumers increasingly demand reef-safe formulations that minimize harm to marine ecosystems, as well as clean-label ingredients free from controversial additives. This paradigm shift has elevated the importance of transparent supply chains and rigorous third-party certifications, influencing procurement strategies and brand positioning. Consequently, businesses that can proactively adapt to these regulatory and consumer imperatives are poised to gain a competitive edge in the evolving isoamyl 4-methoxycinnamate segment

Assessing the Cumulative Impact of United States Tariffs in 2025 on Global Isoamyl 4-Methoxycinnamate Supply Chains and Competitive Structures

The imposition of new U.S. tariffs in 2025 has exerted a cumulative impact on global supply chains for isoamyl 4-methoxycinnamate, altering cost structures and competitive dynamics. Tariff adjustments targeting chemical intermediates sourced from key exporting nations have increased landed costs for manufacturers reliant on offshore production. Consequently, procurement teams are reevaluating long-standing supplier relationships and exploring alternative sourcing strategies to mitigate margin pressures.

In response, several leading players have initiated nearshoring efforts and capacity expansions within North America to offset import levies. These strategic moves not only address cost volatility but also enhance supply chain resilience by shortening lead times and reducing exposure to geopolitical uncertainties. Additionally, collaborative ventures between domestic producers and regional distributors have emerged as a tactical approach to distribute risk and optimize inventory management across diversified channels.

From a competitive standpoint, these tariff-induced adjustments have heightened differentiation among market participants. Organizations with vertically integrated operations or proprietary production technologies are better positioned to absorb duty fluctuations and maintain stable pricing for downstream partners. Meanwhile, smaller entities face increasing pressure to demonstrate agility through flexible contracting and value-added service offerings. As such, a nuanced understanding of tariff implications is indispensable for stakeholders aiming to preserve profitability and secure long-term growth in the isoamyl 4-methoxycinnamate domain

Uncovering Key Segmentation Insights Across Application Forms Distribution Channels and End Use Industries in Isoamyl 4-Methoxycinnamate Market

Segmentation analysis reveals that isoamyl 4-methoxycinnamate applications span a broad spectrum of industries, each with distinct formulation requirements and performance expectations. Within cosmetic formulations, its use extends to hair care products, makeup products, and skin care products where UV protection must be seamlessly integrated without compromising texture or finish. In personal care products, the ingredient enhances bath products and deodorants by offering photoprotective benefits alongside sensory attributes. Pharmaceutical formulations further leverage this compound across oral and topical platforms, capitalizing on its stability and compatibility to support drug delivery systems. Meanwhile, the sunscreen segment bifurcates into inorganic sunscreen formulations and organic sunscreen formulations, with isoamyl 4-methoxycinnamate serving as a key organic filter that complements mineral blockers.

When considered by form, liquid presentations are distinguished into solvent-based liquid systems and water-based liquid systems, each tailored to different manufacturing processes and end-use requirements. Solvent-based variants are prized for their formulation flexibility and rapid skin absorption, whereas water-based options address consumer demand for lighter sensory experiences and eco-friendly compositions. Powder forms are subdivided into micronized powder, which enables fine dispersion and minimal residue, and standard powder for cost-effective mass applications, thereby offering formulators a spectrum of textural and performance characteristics.

Distribution channels play a pivotal role in bringing these diverse product configurations to market. Direct sales models provide tailored support and technical assistance to large-scale manufacturers, while distributors extend reach into regional markets where local inventory management is critical. Concurrently, online retail platforms have surged as a vital conduit for niche and specialty product offerings, connecting innovative brands with digitally engaged consumers. The end use industry further shapes demand patterns, with academic research institutions and contract research organizations driving initial compound investigations, and cosmetics manufacturers translating scientific findings into commercial products that resonate with evolving consumer expectations

Illuminating Regional Nuances Shaping the Isoamyl 4-Methoxycinnamate Market Trends across Americas EMEA and Asia-Pacific Coastal and Inland Dynamics

Regional dynamics exert a profound influence on the adoption and innovation of isoamyl 4-methoxycinnamate, with each geography presenting unique regulatory and market drivers. In the Americas, the United States and Canada showcase mature personal care markets characterized by stringent sunscreen labeling requirements and growing interest in multifunctional formulations. Meanwhile, Latin American markets are witnessing expanding sunscreen penetration driven by elevated UV indices and rising consumer awareness, creating niche opportunities for value-added UV filter innovations.

Europe, Middle East & Africa (EMEA) features a complex regulatory landscape shaped by the European Chemicals Agency’s comprehensive evaluation of UV filter safety and eco-toxicity. This scrutiny has compelled ingredient suppliers to prioritize sustainable production methods and secure green certifications. In parallel, the Middle East’s burgeoning cosmetic sector and Africa’s emerging personal care markets present growth potential underscored by evolving distribution infrastructures and shifting purchasing power.

Asia-Pacific remains a pivotal region, driven by rapid urbanization, a burgeoning middle class, and established sunscreen traditions in coastal nations. China’s accelerated regulatory approvals and Japan’s emphasis on photostable compounds underscore the region’s commitment to high-performance UV filters. At the same time, India’s expanding pharmaceutical and personal care manufacturing base is increasingly exploring advanced UV filter applications, supported by government initiatives that incentivize local production and technology transfers. These regional idiosyncrasies collectively shape a multifaceted landscape for isoamyl 4-methoxycinnamate adoption and innovation

Profiling Leading Companies Influencing the Isoamyl 4-Methoxycinnamate Ecosystem through Strategic Partnerships Innovations and Competitive Positioning

Several industry leaders have established themselves as key proponents of isoamyl 4-methoxycinnamate through strategic research collaborations and targeted capacity expansions. Major chemical conglomerates have invested in proprietary synthesis platforms, enabling cost efficiencies and high-purity product lines. These organizations frequently enter partnerships with leading cosmetic brands to co-develop next-generation UV protection solutions, ensuring rapid market uptake and sustained innovation momentum.

Specialty ingredient manufacturers differentiate themselves by focusing on sustainable supply chain practices and green certification programs. By integrating bio-based feedstocks and closed-loop manufacturing processes, these companies cater to environmentally conscious formulators and regulatory bodies that demand transparency and reduced carbon footprints. Concurrently, niche players have emerged with tailored technical support services, offering custom particle size distributions and emulsification expertise to address the precise needs of contract research organizations and academic laboratories.

Furthermore, digitalization has become a competitive lever, with several forward-thinking firms deploying online formulation platforms and virtual support tools. These digital interfaces enable rapid prototyping, real-time troubleshooting, and enhanced customer engagement, thereby accelerating product development cycles and fostering deeper partnerships across the value chain. Collectively, these strategic initiatives underscore a market where innovation, collaboration, and sustainability form the bedrock of competitive advantage

Formulating Actionable Recommendations for Industry Leaders to Capitalize on Isoamyl 4-Methoxycinnamate Market Opportunities while Mitigating Emerging Risks

To capitalize on the evolving isoamyl 4-methoxycinnamate environment, industry leaders should prioritize supply chain diversification by identifying alternate sourcing hubs and establishing strategic alliances with regional producers. This approach mitigates exposure to tariff disruptions and logistical bottlenecks while fostering local market adaptability. Additionally, investing in green chemistry research to optimize eco-friendly synthesis routes will strengthen regulatory compliance and appeal to environmentally conscious stakeholders.

Proactive engagement with regulatory bodies is essential. Establishing dedicated teams to monitor policy developments and contribute to safety data submissions can expedite approvals and ensure alignment with emerging chemical registration frameworks. Concurrently, leveraging advanced analytics to mine consumer sentiment and formulation performance data will enable targeted product refinements and support evidence-based marketing strategies that resonate with eco-aware and health-focused demographics.

Finally, fostering collaborative R&D initiatives with cosmetics manufacturers, contract research organizations, and academic institutions can accelerate innovation pipelines. By co-creating specialized delivery systems and multifunctional formulations, companies can introduce differentiated offerings that address unmet end user needs. Embracing digital platforms for remote formulation support and virtual trials further enhances speed to market and deepens customer relationships, positioning businesses for sustained leadership in this dynamic space

Detailing a Rigorous Research Methodology for Comprehensive Analysis of Isoamyl 4-Methoxycinnamate Market Insights and Validation through Primary and Secondary Sources

The research methodology underpinning this analysis integrates primary and secondary data to deliver robust insights. Primary research involved in-depth interviews with formulation scientists, regulatory experts, and supply chain executives to capture firsthand perspectives on technical challenges, compliance requirements, and strategic priorities. These qualitative inputs were supplemented by survey responses from cosmetic and pharmaceutical manufacturers to validate emerging trends and identify common pain points.

Secondary research encompassed a comprehensive review of scientific literature, patent filings, and regulatory databases to map innovation trajectories and safety assessments. Publicly available filings from chemical regulatory agencies, peer-reviewed studies on UV filter photostability, and industry white papers provided a foundational evidence base. These sources were cross-referenced with corporate disclosures, sustainability reports, and trade publications to ensure a holistic understanding of market dynamics.

Data triangulation techniques confirmed consistency between qualitative findings and documented market developments. Trend analysis tools were employed to detect shifts in R&D investment patterns, regulatory approval timelines, and consumer preference indicators. This rigorous approach ensures that the conclusions and recommendations presented herein are grounded in validated intelligence, offering stakeholders a dependable framework for strategic decision making

Drawing Conclusive Insights to Synthesize Market Intelligence and Strategic Imperatives for Stakeholders Engaged in the Isoamyl 4-Methoxycinnamate Value Chain

This executive summary has illuminated the multifaceted forces shaping the isoamyl 4-methoxycinnamate market, from foundational material properties and segmentation intricacies to tariff repercussions and regional nuances. The intersection of stringent regulatory landscapes, technological innovation, and consumer expectations underscores the necessity of agile and informed strategic planning. By synthesizing these elements, stakeholders gain clarity on where to focus R&D efforts, how to navigate compliance requirements, and which distribution channels offer optimal market penetration.

The insights presented highlight the importance of sustainability, supply chain resilience, and collaborative innovation as pillars of competitive advantage. Whether through investment in green synthesis, diversification of sourcing strategies, or engagement with digital formulation platforms, proactive measures are paramount. Furthermore, the identification of key regional drivers and application segments empowers decision makers to tailor their approaches and harness localized opportunities.

Ultimately, the path forward requires a harmonious blend of scientific rigor, regulatory foresight, and market responsiveness. Organizations that internalize these strategic imperatives and operationalize the recommendations herein will be well-positioned to lead in the ever-evolving landscape of UV filter applications. Continuous monitoring of policy changes, technological advancements, and consumer trends will ensure enduring success and the ability to pivot in response to future market developments

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • Application
    • Cosmetic Formulations
      • Hair Care Products
      • Makeup Products
      • Skin Care Products
    • Personal Care Products
      • Bath Products
      • Deodorants
    • Pharmaceutical Formulations
      • Oral Formulations
      • Topical Formulations
    • Sunscreen Formulations
      • Inorganic Sunscreen Formulations
      • Organic Sunscreen Formulations
  • Form
    • Liquid Form
      • Solvent Based Liquid
      • Water Based Liquid
    • Powder Form
      • Micronized Powder
      • Standard Powder
  • Distribution Channel
    • Direct Sales
    • Distributors
    • Online Retail
  • End Use Industry
    • Academic Research Institutions
    • Contract Research Organizations
    • Cosmetics Manufacturers
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • United States
      • California
      • Texas
      • New York
      • Florida
      • Illinois
      • Pennsylvania
      • Ohio
    • Canada
    • Mexico
    • Brazil
    • Argentina
  • Europe, Middle East & Africa
    • United Kingdom
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Denmark
    • Netherlands
    • Qatar
    • Finland
    • Sweden
    • Nigeria
    • Egypt
    • Turkey
    • Israel
    • Norway
    • Poland
    • Switzerland
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
    • Malaysia
    • Singapore
    • Vietnam
    • Taiwan
This research report delves into recent significant developments and analyzes trends in each of the following companies:
  • BASF SE
  • Merck KGaA
  • Eastman Chemical Company
  • Zhejiang Heli Chemical Co., Ltd.
  • Sirona Biochem Corp.
  • Aarti Industries Limited
  • Croda International Plc
  • Clariant AG
  • Ashland Global Holdings Inc.
  • Dow Inc.

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Growing consumer demand for eco-friendly and reef-safe UV filters incorporating isoamyl 4-methoxycinnamate
5.2. Regulatory landscape shifts driving reformulation of sunscreen products to include isoamyl 4-methoxycinnamate
5.3. Advances in microencapsulation techniques enhancing the stability and performance of isoamyl 4-methoxycinnamate in formulations
5.4. Strategic partnerships between specialty chemical manufacturers and personal care brands to expand isoamyl 4-methoxycinnamate applications in cosmetics
5.5. Rising interest in multifunctional UV filters combining isoamyl 4-methoxycinnamate with antioxidant actives for premium sun care solutions
5.6. Impact of stringent sunscreen efficacy standards on global supply chain dynamics for isoamyl 4-methoxycinnamate raw materials
5.7. Opportunities in emerging APAC sunscreen markets fueling increased isoamyl 4-methoxycinnamate demand among local manufacturers
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Isoamyl 4-Methoxycinnamate Market, by Application
8.1. Introduction
8.2. Cosmetic Formulations
8.2.1. Hair Care Products
8.2.2. Makeup Products
8.2.3. Skin Care Products
8.3. Personal Care Products
8.3.1. Bath Products
8.3.2. Deodorants
8.4. Pharmaceutical Formulations
8.4.1. Oral Formulations
8.4.2. Topical Formulations
8.5. Sunscreen Formulations
8.5.1. Inorganic Sunscreen Formulations
8.5.2. Organic Sunscreen Formulations
9. Isoamyl 4-Methoxycinnamate Market, by Form
9.1. Introduction
9.2. Liquid Form
9.2.1. Solvent Based Liquid
9.2.2. Water Based Liquid
9.3. Powder Form
9.3.1. Micronized Powder
9.3.2. Standard Powder
10. Isoamyl 4-Methoxycinnamate Market, by Distribution Channel
10.1. Introduction
10.2. Direct Sales
10.3. Distributors
10.4. Online Retail
11. Isoamyl 4-Methoxycinnamate Market, by End Use Industry
11.1. Introduction
11.2. Academic Research Institutions
11.3. Contract Research Organizations
11.4. Cosmetics Manufacturers
12. Americas Isoamyl 4-Methoxycinnamate Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Isoamyl 4-Methoxycinnamate Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Isoamyl 4-Methoxycinnamate Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. BASF SE
15.3.2. Merck KGaA
15.3.3. Eastman Chemical Company
15.3.4. Zhejiang Heli Chemical Co., Ltd.
15.3.5. Sirona Biochem Corp.
15.3.6. Aarti Industries Limited
15.3.7. Croda International Plc
15.3.8. Clariant AG
15.3.9. Ashland Global Holdings Inc.
15.3.10. Dow Inc.
16. ResearchAI
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. ISOAMYL 4-METHOXYCINNAMATE MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 6. GLOBAL ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY FORM, 2024 VS 2030 (%)
FIGURE 8. GLOBAL ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY FORM, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 10. GLOBAL ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY END USE INDUSTRY, 2024 VS 2030 (%)
FIGURE 12. GLOBAL ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY END USE INDUSTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 14. AMERICAS ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 16. UNITED STATES ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ISOAMYL 4-METHOXYCINNAMATE MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 22. ISOAMYL 4-METHOXYCINNAMATE MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 23. ISOAMYL 4-METHOXYCINNAMATE MARKET: RESEARCHAI
FIGURE 24. ISOAMYL 4-METHOXYCINNAMATE MARKET: RESEARCHSTATISTICS
FIGURE 25. ISOAMYL 4-METHOXYCINNAMATE MARKET: RESEARCHCONTACTS
FIGURE 26. ISOAMYL 4-METHOXYCINNAMATE MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. ISOAMYL 4-METHOXYCINNAMATE MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY COSMETIC FORMULATIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY COSMETIC FORMULATIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY HAIR CARE PRODUCTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY HAIR CARE PRODUCTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY MAKEUP PRODUCTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY MAKEUP PRODUCTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY SKIN CARE PRODUCTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY SKIN CARE PRODUCTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY COSMETIC FORMULATIONS, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY COSMETIC FORMULATIONS, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY PERSONAL CARE PRODUCTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY PERSONAL CARE PRODUCTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY BATH PRODUCTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY BATH PRODUCTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY DEODORANTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY DEODORANTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY PERSONAL CARE PRODUCTS, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY PERSONAL CARE PRODUCTS, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY PHARMACEUTICAL FORMULATIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY PHARMACEUTICAL FORMULATIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY ORAL FORMULATIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY ORAL FORMULATIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY TOPICAL FORMULATIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY TOPICAL FORMULATIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY PHARMACEUTICAL FORMULATIONS, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY PHARMACEUTICAL FORMULATIONS, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY SUNSCREEN FORMULATIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY SUNSCREEN FORMULATIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY INORGANIC SUNSCREEN FORMULATIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY INORGANIC SUNSCREEN FORMULATIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY ORGANIC SUNSCREEN FORMULATIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY ORGANIC SUNSCREEN FORMULATIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY SUNSCREEN FORMULATIONS, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY SUNSCREEN FORMULATIONS, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY LIQUID FORM, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY LIQUID FORM, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY SOLVENT BASED LIQUID, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY SOLVENT BASED LIQUID, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY WATER BASED LIQUID, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY WATER BASED LIQUID, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY LIQUID FORM, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY LIQUID FORM, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY POWDER FORM, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY POWDER FORM, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY MICRONIZED POWDER, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY MICRONIZED POWDER, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY STANDARD POWDER, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY STANDARD POWDER, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY POWDER FORM, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY POWDER FORM, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY DIRECT SALES, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY ONLINE RETAIL, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY ONLINE RETAIL, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY END USE INDUSTRY, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY END USE INDUSTRY, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY COSMETICS MANUFACTURERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY COSMETICS MANUFACTURERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. AMERICAS ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 80. AMERICAS ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 81. AMERICAS ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY COSMETIC FORMULATIONS, 2018-2024 (USD MILLION)
TABLE 82. AMERICAS ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY COSMETIC FORMULATIONS, 2025-2030 (USD MILLION)
TABLE 83. AMERICAS ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY PERSONAL CARE PRODUCTS, 2018-2024 (USD MILLION)
TABLE 84. AMERICAS ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY PERSONAL CARE PRODUCTS, 2025-2030 (USD MILLION)
TABLE 85. AMERICAS ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY PHARMACEUTICAL FORMULATIONS, 2018-2024 (USD MILLION)
TABLE 86. AMERICAS ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY PHARMACEUTICAL FORMULATIONS, 2025-2030 (USD MILLION)
TABLE 87. AMERICAS ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY SUNSCREEN FORMULATIONS, 2018-2024 (USD MILLION)
TABLE 88. AMERICAS ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY SUNSCREEN FORMULATIONS, 2025-2030 (USD MILLION)
TABLE 89. AMERICAS ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 90. AMERICAS ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 91. AMERICAS ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY LIQUID FORM, 2018-2024 (USD MILLION)
TABLE 92. AMERICAS ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY LIQUID FORM, 2025-2030 (USD MILLION)
TABLE 93. AMERICAS ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY POWDER FORM, 2018-2024 (USD MILLION)
TABLE 94. AMERICAS ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY POWDER FORM, 2025-2030 (USD MILLION)
TABLE 95. AMERICAS ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 96. AMERICAS ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 97. AMERICAS ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY END USE INDUSTRY, 2018-2024 (USD MILLION)
TABLE 98. AMERICAS ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY END USE INDUSTRY, 2025-2030 (USD MILLION)
TABLE 99. AMERICAS ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 100. AMERICAS ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 101. UNITED STATES ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 102. UNITED STATES ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 103. UNITED STATES ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY COSMETIC FORMULATIONS, 2018-2024 (USD MILLION)
TABLE 104. UNITED STATES ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY COSMETIC FORMULATIONS, 2025-2030 (USD MILLION)
TABLE 105. UNITED STATES ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY PERSONAL CARE PRODUCTS, 2018-2024 (USD MILLION)
TABLE 106. UNITED STATES ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY PERSONAL CARE PRODUCTS, 2025-2030 (USD MILLION)
TABLE 107. UNITED STATES ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY PHARMACEUTICAL FORMULATIONS, 2018-2024 (USD MILLION)
TABLE 108. UNITED STATES ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY PHARMACEUTICAL FORMULATIONS, 2025-2030 (USD MILLION)
TABLE 109. UNITED STATES ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY SUNSCREEN FORMULATIONS, 2018-2024 (USD MILLION)
TABLE 110. UNITED STATES ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY SUNSCREEN FORMULATIONS, 2025-2030 (USD MILLION)
TABLE 111. UNITED STATES ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 112. UNITED STATES ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 113. UNITED STATES ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY LIQUID FORM, 2018-2024 (USD MILLION)
TABLE 114. UNITED STATES ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY LIQUID FORM, 2025-2030 (USD MILLION)
TABLE 115. UNITED STATES ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY POWDER FORM, 2018-2024 (USD MILLION)
TABLE 116. UNITED STATES ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY POWDER FORM, 2025-2030 (USD MILLION)
TABLE 117. UNITED STATES ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 118. UNITED STATES ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 119. UNITED STATES ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY END USE INDUSTRY, 2018-2024 (USD MILLION)
TABLE 120. UNITED STATES ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY END USE INDUSTRY, 2025-2030 (USD MILLION)
TABLE 121. UNITED STATES ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 122. UNITED STATES ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 123. CANADA ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 124. CANADA ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 125. CANADA ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY COSMETIC FORMULATIONS, 2018-2024 (USD MILLION)
TABLE 126. CANADA ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY COSMETIC FORMULATIONS, 2025-2030 (USD MILLION)
TABLE 127. CANADA ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY PERSONAL CARE PRODUCTS, 2018-2024 (USD MILLION)
TABLE 128. CANADA ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY PERSONAL CARE PRODUCTS, 2025-2030 (USD MILLION)
TABLE 129. CANADA ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY PHARMACEUTICAL FORMULATIONS, 2018-2024 (USD MILLION)
TABLE 130. CANADA ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY PHARMACEUTICAL FORMULATIONS, 2025-2030 (USD MILLION)
TABLE 131. CANADA ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY SUNSCREEN FORMULATIONS, 2018-2024 (USD MILLION)
TABLE 132. CANADA ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY SUNSCREEN FORMULATIONS, 2025-2030 (USD MILLION)
TABLE 133. CANADA ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 134. CANADA ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 135. CANADA ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY LIQUID FORM, 2018-2024 (USD MILLION)
TABLE 136. CANADA ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY LIQUID FORM, 2025-2030 (USD MILLION)
TABLE 137. CANADA ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY POWDER FORM, 2018-2024 (USD MILLION)
TABLE 138. CANADA ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY POWDER FORM, 2025-2030 (USD MILLION)
TABLE 139. CANADA ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 140. CANADA ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 141. CANADA ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY END USE INDUSTRY, 2018-2024 (USD MILLION)
TABLE 142. CANADA ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY END USE INDUSTRY, 2025-2030 (USD MILLION)
TABLE 143. MEXICO ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 144. MEXICO ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 145. MEXICO ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY COSMETIC FORMULATIONS, 2018-2024 (USD MILLION)
TABLE 146. MEXICO ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY COSMETIC FORMULATIONS, 2025-2030 (USD MILLION)
TABLE 147. MEXICO ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY PERSONAL CARE PRODUCTS, 2018-2024 (USD MILLION)
TABLE 148. MEXICO ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY PERSONAL CARE PRODUCTS, 2025-2030 (USD MILLION)
TABLE 149. MEXICO ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY PHARMACEUTICAL FORMULATIONS, 2018-2024 (USD MILLION)
TABLE 150. MEXICO ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY PHARMACEUTICAL FORMULATIONS, 2025-2030 (USD MILLION)
TABLE 151. MEXICO ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY SUNSCREEN FORMULATIONS, 2018-2024 (USD MILLION)
TABLE 152. MEXICO ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY SUNSCREEN FORMULATIONS, 2025-2030 (USD MILLION)
TABLE 153. MEXICO ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 154. MEXICO ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 155. MEXICO ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY LIQUID FORM, 2018-2024 (USD MILLION)
TABLE 156. MEXICO ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY LIQUID FORM, 2025-2030 (USD MILLION)
TABLE 157. MEXICO ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY POWDER FORM, 2018-2024 (USD MILLION)
TABLE 158. MEXICO ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY POWDER FORM, 2025-2030 (USD MILLION)
TABLE 159. MEXICO ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 160. MEXICO ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 161. MEXICO ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY END USE INDUSTRY, 2018-2024 (USD MILLION)
TABLE 162. MEXICO ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY END USE INDUSTRY, 2025-2030 (USD MILLION)
TABLE 163. BRAZIL ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 164. BRAZIL ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 165. BRAZIL ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY COSMETIC FORMULATIONS, 2018-2024 (USD MILLION)
TABLE 166. BRAZIL ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY COSMETIC FORMULATIONS, 2025-2030 (USD MILLION)
TABLE 167. BRAZIL ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY PERSONAL CARE PRODUCTS, 2018-2024 (USD MILLION)
TABLE 168. BRAZIL ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY PERSONAL CARE PRODUCTS, 2025-2030 (USD MILLION)
TABLE 169. BRAZIL ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY PHARMACEUTICAL FORMULATIONS, 2018-2024 (USD MILLION)
TABLE 170. BRAZIL ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY PHARMACEUTICAL FORMULATIONS, 2025-2030 (USD MILLION)
TABLE 171. BRAZIL ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY SUNSCREEN FORMULATIONS, 2018-2024 (USD MILLION)
TABLE 172. BRAZIL ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY SUNSCREEN FORMULATIONS, 2025-2030 (USD MILLION)
TABLE 173. BRAZIL ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 174. BRAZIL ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 175. BRAZIL ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY LIQUID FORM, 2018-2024 (USD MILLION)
TABLE 176. BRAZIL ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY LIQUID FORM, 2025-2030 (USD MILLION)
TABLE 177. BRAZIL ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY POWDER FORM, 2018-2024 (USD MILLION)
TABLE 178. BRAZIL ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY POWDER FORM, 2025-2030 (USD MILLION)
TABLE 179. BRAZIL ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 180. BRAZIL ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 181. BRAZIL ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY END USE INDUSTRY, 2018-2024 (USD MILLION)
TABLE 182. BRAZIL ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY END USE INDUSTRY, 2025-2030 (USD MILLION)
TABLE 183. ARGENTINA ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 184. ARGENTINA ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 185. ARGENTINA ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY COSMETIC FORMULATIONS, 2018-2024 (USD MILLION)
TABLE 186. ARGENTINA ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY COSMETIC FORMULATIONS, 2025-2030 (USD MILLION)
TABLE 187. ARGENTINA ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY PERSONAL CARE PRODUCTS, 2018-2024 (USD MILLION)
TABLE 188. ARGENTINA ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY PERSONAL CARE PRODUCTS, 2025-2030 (USD MILLION)
TABLE 189. ARGENTINA ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY PHARMACEUTICAL FORMULATIONS, 2018-2024 (USD MILLION)
TABLE 190. ARGENTINA ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY PHARMACEUTICAL FORMULATIONS, 2025-2030 (USD MILLION)
TABLE 191. ARGENTINA ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY SUNSCREEN FORMULATIONS, 2018-2024 (USD MILLION)
TABLE 192. ARGENTINA ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY SUNSCREEN FORMULATIONS, 2025-2030 (USD MILLION)
TABLE 193. ARGENTINA ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 194. ARGENTINA ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 195. ARGENTINA ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY LIQUID FORM, 2018-2024 (USD MILLION)
TABLE 196. ARGENTINA ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY LIQUID FORM, 2025-2030 (USD MILLION)
TABLE 197. ARGENTINA ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY POWDER FORM, 2018-2024 (USD MILLION)
TABLE 198. ARGENTINA ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY POWDER FORM, 2025-2030 (USD MILLION)
TABLE 199. ARGENTINA ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 200. ARGENTINA ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 201. ARGENTINA ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY END USE INDUSTRY, 2018-2024 (USD MILLION)
TABLE 202. ARGENTINA ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY END USE INDUSTRY, 2025-2030 (USD MILLION)
TABLE 203. EUROPE, MIDDLE EAST & AFRICA ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 204. EUROPE, MIDDLE EAST & AFRICA ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 205. EUROPE, MIDDLE EAST & AFRICA ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY COSMETIC FORMULATIONS, 2018-2024 (USD MILLION)
TABLE 206. EUROPE, MIDDLE EAST & AFRICA ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY COSMETIC FORMULATIONS, 2025-2030 (USD MILLION)
TABLE 207. EUROPE, MIDDLE EAST & AFRICA ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY PERSONAL CARE PRODUCTS, 2018-2024 (USD MILLION)
TABLE 208. EUROPE, MIDDLE EAST & AFRICA ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY PERSONAL CARE PRODUCTS, 2025-2030 (USD MILLION)
TABLE 209. EUROPE, MIDDLE EAST & AFRICA ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY PHARMACEUTICAL FORMULATIONS, 2018-2024 (USD MILLION)
TABLE 210. EUROPE, MIDDLE EAST & AFRICA ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY PHARMACEUTICAL FORMULATIONS, 2025-2030 (USD MILLION)
TABLE 211. EUROPE, MIDDLE EAST & AFRICA ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY SUNSCREEN FORMULATIONS, 2018-2024 (USD MILLION)
TABLE 212. EUROPE, MIDDLE EAST & AFRICA ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY SUNSCREEN FORMULATIONS, 2025-2030 (USD MILLION)
TABLE 213. EUROPE, MIDDLE EAST & AFRICA ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 214. EUROPE, MIDDLE EAST & AFRICA ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 215. EUROPE, MIDDLE EAST & AFRICA ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY LIQUID FORM, 2018-2024 (USD MILLION)
TABLE 216. EUROPE, MIDDLE EAST & AFRICA ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY LIQUID FORM, 2025-2030 (USD MILLION)
TABLE 217. EUROPE, MIDDLE EAST & AFRICA ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY POWDER FORM, 2018-2024 (USD MILLION)
TABLE 218. EUROPE, MIDDLE EAST & AFRICA ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY POWDER FORM, 2025-2030 (USD MILLION)
TABLE 219. EUROPE, MIDDLE EAST & AFRICA ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 220. EUROPE, MIDDLE EAST & AFRICA ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 221. EUROPE, MIDDLE EAST & AFRICA ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY END USE INDUSTRY, 2018-2024 (USD MILLION)
TABLE 222. EUROPE, MIDDLE EAST & AFRICA ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY END USE INDUSTRY, 2025-2030 (USD MILLION)
TABLE 223. EUROPE, MIDDLE EAST & AFRICA ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 224. EUROPE, MIDDLE EAST & AFRICA ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 225. UNITED KINGDOM ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 226. UNITED KINGDOM ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 227. UNITED KINGDOM ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY COSMETIC FORMULATIONS, 2018-2024 (USD MILLION)
TABLE 228. UNITED KINGDOM ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY COSMETIC FORMULATIONS, 2025-2030 (USD MILLION)
TABLE 229. UNITED KINGDOM ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY PERSONAL CARE PRODUCTS, 2018-2024 (USD MILLION)
TABLE 230. UNITED KINGDOM ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY PERSONAL CARE PRODUCTS, 2025-2030 (USD MILLION)
TABLE 231. UNITED KINGDOM ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY PHARMACEUTICAL FORMULATIONS, 2018-2024 (USD MILLION)
TABLE 232. UNITED KINGDOM ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY PHARMACEUTICAL FORMULATIONS, 2025-2030 (USD MILLION)
TABLE 233. UNITED KINGDOM ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY SUNSCREEN FORMULATIONS, 2018-2024 (USD MILLION)
TABLE 234. UNITED KINGDOM ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY SUNSCREEN FORMULATIONS, 2025-2030 (USD MILLION)
TABLE 235. UNITED KINGDOM ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 236. UNITED KINGDOM ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 237. UNITED KINGDOM ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY LIQUID FORM, 2018-2024 (USD MILLION)
TABLE 238. UNITED KINGDOM ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY LIQUID FORM, 2025-2030 (USD MILLION)
TABLE 239. UNITED KINGDOM ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY POWDER FORM, 2018-2024 (USD MILLION)
TABLE 240. UNITED KINGDOM ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY POWDER FORM, 2025-2030 (USD MILLION)
TABLE 241. UNITED KINGDOM ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 242. UNITED KINGDOM ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 243. UNITED KINGDOM ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY END USE INDUSTRY, 2018-2024 (USD MILLION)
TABLE 244. UNITED KINGDOM ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY END USE INDUSTRY, 2025-2030 (USD MILLION)
TABLE 245. GERMANY ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 246. GERMANY ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 247. GERMANY ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY COSMETIC FORMULATIONS, 2018-2024 (USD MILLION)
TABLE 248. GERMANY ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY COSMETIC FORMULATIONS, 2025-2030 (USD MILLION)
TABLE 249. GERMANY ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY PERSONAL CARE PRODUCTS, 2018-2024 (USD MILLION)
TABLE 250. GERMANY ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY PERSONAL CARE PRODUCTS, 2025-2030 (USD MILLION)
TABLE 251. GERMANY ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY PHARMACEUTICAL FORMULATIONS, 2018-2024 (USD MILLION)
TABLE 252. GERMANY ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY PHARMACEUTICAL FORMULATIONS, 2025-2030 (USD MILLION)
TABLE 253. GERMANY ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY SUNSCREEN FORMULATIONS, 2018-2024 (USD MILLION)
TABLE 254. GERMANY ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY SUNSCREEN FORMULATIONS, 2025-2030 (USD MILLION)
TABLE 255. GERMANY ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 256. GERMANY ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 257. GERMANY ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY LIQUID FORM, 2018-2024 (USD MILLION)
TABLE 258. GERMANY ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY LIQUID FORM, 2025-2030 (USD MILLION)
TABLE 259. GERMANY ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY POWDER FORM, 2018-2024 (USD MILLION)
TABLE 260. GERMANY ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY POWDER FORM, 2025-2030 (USD MILLION)
TABLE 261. GERMANY ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 262. GERMANY ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 263. GERMANY ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY END USE INDUSTRY, 2018-2024 (USD MILLION)
TABLE 264. GERMANY ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY END USE INDUSTRY, 2025-2030 (USD MILLION)
TABLE 265. FRANCE ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 266. FRANCE ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 267. FRANCE ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY COSMETIC FORMULATIONS, 2018-2024 (USD MILLION)
TABLE 268. FRANCE ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY COSMETIC FORMULATIONS, 2025-2030 (USD MILLION)
TABLE 269. FRANCE ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY PERSONAL CARE PRODUCTS, 2018-2024 (USD MILLION)
TABLE 270. FRANCE ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY PERSONAL CARE PRODUCTS, 2025-2030 (USD MILLION)
TABLE 271. FRANCE ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY PHARMACEUTICAL FORMULATIONS, 2018-2024 (USD MILLION)
TABLE 272. FRANCE ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY PHARMACEUTICAL FORMULATIONS, 2025-2030 (USD MILLION)
TABLE 273. FRANCE ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY SUNSCREEN FORMULATIONS, 2018-2024 (USD MILLION)
TABLE 274. FRANCE ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY SUNSCREEN FORMULATIONS, 2025-2030 (USD MILLION)
TABLE 275. FRANCE ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 276. FRANCE ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 277. FRANCE ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY LIQUID FORM, 2018-2024 (USD MILLION)
TABLE 278. FRANCE ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY LIQUID FORM, 2025-2030 (USD MILLION)
TABLE 279. FRANCE ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY POWDER FORM, 2018-2024 (USD MILLION)
TABLE 280. FRANCE ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY POWDER FORM, 2025-2030 (USD MILLION)
TABLE 281. FRANCE ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 282. FRANCE ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 283. FRANCE ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY END USE INDUSTRY, 2018-2024 (USD MILLION)
TABLE 284. FRANCE ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY END USE INDUSTRY, 2025-2030 (USD MILLION)
TABLE 285. RUSSIA ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 286. RUSSIA ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 287. RUSSIA ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY COSMETIC FORMULATIONS, 2018-2024 (USD MILLION)
TABLE 288. RUSSIA ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY COSMETIC FORMULATIONS, 2025-2030 (USD MILLION)
TABLE 289. RUSSIA ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY PERSONAL CARE PRODUCTS, 2018-2024 (USD MILLION)
TABLE 290. RUSSIA ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY PERSONAL CARE PRODUCTS, 2025-2030 (USD MILLION)
TABLE 291. RUSSIA ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY PHARMACEUTICAL FORMULATIONS, 2018-2024 (USD MILLION)
TABLE 292. RUSSIA ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY PHARMACEUTICAL FORMULATIONS, 2025-2030 (USD MILLION)
TABLE 293. RUSSIA ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY SUNSCREEN FORMULATIONS, 2018-2024 (USD MILLION)
TABLE 294. RUSSIA ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY SUNSCREEN FORMULATIONS, 2025-2030 (USD MILLION)
TABLE 295. RUSSIA ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 296. RUSSIA ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 297. RUSSIA ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY LIQUID FORM, 2018-2024 (USD MILLION)
TABLE 298. RUSSIA ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY LIQUID FORM, 2025-2030 (USD MILLION)
TABLE 299. RUSSIA ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY POWDER FORM, 2018-2024 (USD MILLION)
TABLE 300. RUSSIA ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY POWDER FORM, 2025-2030 (USD MILLION)
TABLE 301. RUSSIA ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 302. RUSSIA ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 303. RUSSIA ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY END USE INDUSTRY, 2018-2024 (USD MILLION)
TABLE 304. RUSSIA ISOAMYL 4-METHOXYCINNAMATE MARKET SIZE, BY END USE INDUSTRY, 2025-2030 (USD MILLION)
TABLE 305. ITALY ISOAMYL 4-METH

Companies Mentioned

The companies profiled in this Isoamyl 4-Methoxycinnamate market report include:
  • BASF SE
  • Merck KGaA
  • Eastman Chemical Company
  • Zhejiang Heli Chemical Co., Ltd.
  • Sirona Biochem Corp.
  • Aarti Industries Limited
  • Croda International Plc
  • Clariant AG
  • Ashland Global Holdings Inc.
  • Dow Inc.